Can methocarbamol (Robaxin) and gabapentin be taken together?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 13, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can Robaxin and Gabapentin Be Given Together?

Yes, methocarbamol (Robaxin) and gabapentin can be taken together—there are no documented drug interactions between these medications, and they are frequently co-prescribed in clinical practice for pain management.

Evidence for Concurrent Use

The FDA drug labels for both medications do not list any contraindications or interactions with each other. The gabapentin label 1 extensively details drug interactions with multiple medications (phenytoin, carbamazepine, valproic acid, hydrocodone, morphine, antacids, and others), but methocarbamol is notably absent from this list. Similarly, the methocarbamol label 2 warns about CNS depressant effects with alcohol and other CNS depressants but does not specifically contraindicate gabapentin.

Clinical Practice Evidence

Multiple studies demonstrate these medications are routinely used together:

  • Traumatic brain injury rehabilitation: A 2023 study found that concurrent use of gabapentin and methocarbamol was associated with reduced opioid requirements, with both medications showing independent beneficial effects on morphine milligram equivalents 3

  • Orthopedic surgery: A case report documented successful opioid-free pain management after total knee arthroplasty using a multimodal regimen that included both gabapentin and methocarbamol together, along with other non-opioid analgesics 4

  • Veterinary medicine: Even in animal cases, gabapentin, tramadol, and methocarbamol have been prescribed concurrently 5

Important Safety Considerations

CNS Depression Risk

Both medications can cause central nervous system depression, so the primary concern is additive sedation, drowsiness, and dizziness.

  • Methocarbamol warnings 2: May impair mental/physical abilities; caution with alcohol and other CNS depressants
  • Gabapentin effects: Can cause somnolence and dizziness 1

Practical Management

When prescribing both medications together:

  • Start with lower doses of each medication and titrate based on response
  • Counsel patients explicitly about:
    • Avoiding alcohol
    • Not driving or operating machinery until they know how the combination affects them
    • Risk of increased drowsiness, especially during the first few days
  • Monitor closely in elderly patients (≥65 years) who are at higher risk for falls and confusion
  • Adjust for renal impairment: Gabapentin requires dose reduction in kidney disease 1; methocarbamol elimination is impaired in renal disease 6

Perioperative Context

If surgery is planned, guidelines recommend holding methocarbamol on the day of operation 6, while gabapentin management should be individualized based on the clinical scenario and type of surgery.

Clinical Bottom Line

There is no pharmacologic interaction preventing concurrent use of methocarbamol and gabapentin. The combination is used in clinical practice and may provide complementary pain relief through different mechanisms. The main precaution is monitoring for additive CNS depressant effects, particularly sedation and impaired coordination. This combination may actually reduce opioid requirements in certain pain conditions 3.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.